NO971332D0 - Fremstilling av krystallinsk penem - Google Patents

Fremstilling av krystallinsk penem

Info

Publication number
NO971332D0
NO971332D0 NO971332A NO971332A NO971332D0 NO 971332 D0 NO971332 D0 NO 971332D0 NO 971332 A NO971332 A NO 971332A NO 971332 A NO971332 A NO 971332A NO 971332 D0 NO971332 D0 NO 971332D0
Authority
NO
Norway
Prior art keywords
preparation
penem
crystalline
crystalline penem
Prior art date
Application number
NO971332A
Other languages
English (en)
Other versions
NO971332L (no
Inventor
Masayoshi Kaneko
Shigeo Yabuno
Original Assignee
Lederle Japan Ltd
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO971332L publication Critical patent/NO971332L/no
Application filed by Lederle Japan Ltd, Takeda Chemical Industries Ltd filed Critical Lederle Japan Ltd
Publication of NO971332D0 publication Critical patent/NO971332D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO971332A 1991-09-20 1997-03-21 Fremstilling av krystallinsk penem NO971332D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24164891 1991-09-20

Publications (2)

Publication Number Publication Date
NO971332L NO971332L (no) 1993-03-22
NO971332D0 true NO971332D0 (no) 1997-03-21

Family

ID=17077445

Family Applications (2)

Application Number Title Priority Date Filing Date
NO92923619A NO923619L (no) 1991-09-20 1992-09-17 Fremstilling av krystallinsk penem
NO971332A NO971332D0 (no) 1991-09-20 1997-03-21 Fremstilling av krystallinsk penem

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO92923619A NO923619L (no) 1991-09-20 1992-09-17 Fremstilling av krystallinsk penem

Country Status (9)

Country Link
US (2) US5286856A (no)
EP (1) EP0533149A1 (no)
JP (1) JP2767171B2 (no)
KR (1) KR930006022A (no)
FI (1) FI924210A7 (no)
IL (1) IL103218A0 (no)
NO (2) NO923619L (no)
TW (1) TW264475B (no)
ZA (1) ZA927164B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW264475B (no) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
WO1995029913A1 (en) * 1994-05-02 1995-11-09 Shionogi & Co., Ltd. Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same
CA2322658C (en) * 1998-03-02 2005-04-12 Merck & Co., Inc. Process for synthesizing carbapenem antibiotics
DE10300620B4 (de) * 2002-05-18 2017-04-13 Carl Zeiss Meditec Ag Trägervorrichtung für ein medizinisch-optisches Gerät
KR101013535B1 (ko) * 2004-10-21 2011-02-14 주식회사 만도 자동차의 파워 스티어링 장치용 실린더 튜브와 피드튜브의 조립 구조물
PL2076501T3 (pl) 2006-09-25 2016-06-30 Ptc Therapeutics Inc Postacie krystaliczne kwasu 3-[5-(2-fluorofenylo)[1,2,4]oksadiazol-3-ilo]-benzoesowego
WO2009047604A1 (en) * 2007-10-08 2009-04-16 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
DE102008043318A1 (de) 2008-10-30 2010-05-12 Mvg Metallverarbeitungsgesellschaft Mbh Anhängekupplung
WO2013132422A1 (en) * 2012-03-05 2013-09-12 Orchid Chemicals & Pharmaceuticals Ltd An improved process for the preparation of carbapenem antibiotic
RU2693898C2 (ru) 2012-05-30 2019-07-05 Мейдзи Сейка Фарма Ко., Лтд. НОВЫЙ ИНГИБИТОР бета-ЛАКТАМАЗЫ И СПОСОБ ЕГО ПОЛУЧЕНИЯ
WO2014097221A1 (en) 2012-12-21 2014-06-26 Ranbaxy Laboratories Limited Process for the purification of biapenem
DK3050883T3 (da) 2013-09-24 2020-05-25 Meiji Seika Pharma Co Ltd Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter
EP3613740A1 (en) 2013-10-08 2020-02-26 Meiji Seika Pharma Co., Ltd. Preparation of a diazabicyclooctane derivative
RU2732129C2 (ru) 2014-12-05 2020-09-11 Мейдзи Сейка Фарма Ко., Лтд. Способ производства кристаллов производного диазабициклооктана и стабильного лиофилизированного препарата
CN114349772B (zh) * 2020-10-13 2022-11-25 珠海联邦制药股份有限公司 一种比阿培南粗品的精制方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029655A (en) * 1975-04-11 1977-06-14 Eli Lilly And Company Method of preparing stable sterile crystalline cephalosporins for parenteral administration
IL53427A0 (en) * 1976-11-24 1978-01-31 Lilly Co Eli Method of preparing a rapidly dissolving powder of sterile crystalline cefozolin sodium for parenteral administration
JPS6024080B2 (ja) * 1977-06-01 1985-06-11 武田薬品工業株式会社 結晶の製造法
GB1589317A (en) * 1977-11-24 1981-05-13 Lilly Co Eli Freeze drying cephalothin sodium
JPS56120615A (en) * 1980-02-27 1981-09-22 Nippon Chemiphar Co Ltd Preparation of lyophilized powder of cephalothin
US4713451A (en) * 1984-04-09 1987-12-15 Merck & Co., Inc. Crystalline dimethyliminothienamycin
IE60588B1 (en) * 1986-07-30 1994-07-27 Sumitomo Pharma Carbapenem compound in crystalline form, and its production and use
US4866171A (en) * 1987-04-11 1989-09-12 Lederle (Japan), Ltd. (1R,5S,6S)-2-[(6,7-dihydro-5H-pyrazolo[1,2-a][1,2,4]triazolium-6-yl)]thio-6-[R-1-hydroxyethyl]-1-methyl-carbapenum-3-carboxylate
JPS6425779A (en) * 1987-04-11 1989-01-27 Lederle Japan Ltd (1r,5s,6s)-2-substituted-thio-6-((r)-1-hydroxyethyl)-1-methyl -carbapenem-3-carboxylic acid derivative
DK168047B1 (da) * 1987-12-07 1994-01-24 Lederle Japan Ltd (1r,5s,6s)-2-substitueret thio-6-oe(r)-1-hydroxyethylaa-1-methyl-carbapenem-3-carboxylsyrederivater, fremgangsmaade til remstilling deraf, midler og praeparater indeholdende den krystallinske forbindelse samt dens anvendelse.
US5082661A (en) * 1990-09-26 1992-01-21 Elizabeth Arden Co., Division Of Conopco, Inc. Odorless cosmetic compositions in gelatin capsules
GB9021061D0 (en) * 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
TW264475B (no) * 1991-09-20 1995-12-01 Takeda Pharm Industry Co Ltd
CN1046285C (zh) * 1993-01-29 1999-11-10 阿格罗尼制药公司 作为抗增殖剂的稠合杂环谷氨酸衍生物

Also Published As

Publication number Publication date
JP2767171B2 (ja) 1998-06-18
US5286856A (en) 1994-02-15
NO971332L (no) 1993-03-22
KR930006022A (ko) 1993-04-20
FI924210A0 (fi) 1992-09-18
FI924210L (fi) 1993-03-21
FI924210A7 (fi) 1993-03-21
NO923619L (no) 1993-03-22
ZA927164B (en) 1994-03-18
AU2459792A (en) 1993-03-25
EP0533149A1 (en) 1993-03-24
AU645442B2 (en) 1994-01-13
IL103218A0 (en) 1993-02-21
TW264475B (no) 1995-12-01
JPH05271241A (ja) 1993-10-19
US5424069A (en) 1995-06-13
NO923619D0 (no) 1992-09-17

Similar Documents

Publication Publication Date Title
FI924745A7 (fi) Kiteisen selluloosan valmistus
NO921976L (no) Amidestere av rapamycin
NO921217L (no) Silyletere av rapamycin
NO933413L (no) Stereoselektiv fremstilling av substituerte piperidiner
NO934547D0 (no) Oral behandling av Helicobacter-in-feksjon
NO171791C (no) Krystallinske copolymerer av propylen
FI934422L (fi) Bibliotek av heterodimera receptorer med anvaendning av fagemider
FI933882L (fi) Styrning av cellulaer immunitet med receptorchimera
FI931406L (fi) Foerfarande foer framstaellning av lineariskt polyeten med laog taethet
FI923119A7 (fi) Krutdriven montageanordning med magasin foer faestelement
NO921810L (no) Anvendelse av acetaler
FI933736L (fi) Behandling av cellulit med retinoider
NO923619D0 (no) Fremstilling av krystallinsk penem
FI962937A0 (fi) Kefuroksiimiaksetiilin biohyödynnettävä kidemuoto
FI933814L (fi) Framstaellning av faktor-ix
FI933542A0 (fi) Blekning av lignocellulosamaterial med aktiverat syre
FI921811A7 (fi) Foerfarande foer framstaellning av maongskiktspappers- och maongskiktspapprodukter med oekad styvhet
FI931583L (fi) Foerfarande foer framstaellning av optiskt aktiva cyanhydriner med hjaelp av enzymer
FI922385L (fi) Foerfarande foer reglering av ensymaktiviter med aedelgaser
FI925416A0 (fi) Framstaellning av metalloxidsoler med elektrolys
FI934083A0 (fi) Foerfarande foer behandling av bomullshaltiga vaevnader med cellulas
NO940190D0 (no) Anvendelse av x-ketoglutarat
FI922443L (fi) Framstaellning av 6-o-alkylelsamicin-a-derivat
NO920272D0 (no) Hydrofile-hydrofobe derivater av polygalaktomannaner inneholdende tertiaer aminfunksjonalitet
NO922864D0 (no) Fremstilling av pradimicinantibiotika